(WTW) Willis Towers Watson - Ratings and Ratios

Exchange: NASDAQ • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: IE00BDB6Q211

WTW: Insurance Brokerage, Consulting, Risk Management, Investment, Software

Willis Towers Watson Public Limited Company (WTW) is a global leader in advisory, broking, and solutions, operating through two primary segments: Health, Wealth & Career and Risk & Broking. The company provides comprehensive services including strategy and design consulting, plan management, and broking for health and retirement plans. It offers actuarial support, retirement consulting, and integrated solutions such as investment management and pension administration. WTW also addresses total rewards and talent issues with data, software, and products, and provides risk advice and insurance brokerage across various industries. Additionally, WTW offers software, risk management, and business services, positioning itself as a holistic solutions provider in the insurance and consulting sectors.

Founded in 1828 and headquartered in London, WTW rebranded from Willis Group Holdings in 2016. With a market capitalization of $31.97 billion, WTW is a significant player in the multi-line insurance industry. The companys forward P/E of 18.42 indicates growth expectations, while a P/B ratio of 4.03 reflects market valuation of its assets. However, a negative RoE of -1.23 may signal profitability challenges. WTWs diverse service offerings and global reach underscore its role as a key advisor to organizations worldwide.

3-Month Forecast: WTWs stock is currently trading at 321.00, below its SMA20 (326.49) and SMA50 (327.16), suggesting short-term weakness. Support is anticipated at the SMA200 level of 303.47. The ATR of 8.45 indicates moderate volatility, with potential price fluctuations within an 8-point range. While the negative RoE may concern investors, the forward P/E suggests optimism for future earnings. Resistance levels around 326-327 could test the stocks upward momentum, with potential upside if these levels are breached.

Additional Sources for WTW Stock

WTW Stock Overview

Market Cap in USD 30,445m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Multi-line Insurance
IPO / Inception 2016-01-05

WTW Stock Ratings

Growth Rating 69.4
Fundamental 5.25
Dividend Rating 56.5
Rel. Strength -0.77
Analysts 4.11/5
Fair Price Momentum 316.88 USD
Fair Price DCF 327.37 USD

WTW Dividends

Dividend Yield 12m 1.18%
Yield on Cost 5y 2.08%
Annual Growth 5y 5.06%
Payout Consistency 97.4%

WTW Growth Ratios

Growth Correlation 3m -24.3%
Growth Correlation 12m 92.2%
Growth Correlation 5y 78.7%
CAGR 5y 12.29%
CAGR/Max DD 5y 0.43
Sharpe Ratio 12m 1.24
Alpha 13.65
Beta 0.438
Volatility 32.83%
Current Volume 577k
Average Volume 20d 702.1k
What is the price of WTW stocks?
As of May 02, 2025, the stock is trading at USD 306.36 with a total of 576,960 shares traded.
Over the past week, the price has changed by -0.23%, over one month by -9.09%, over three months by -7.10% and over the past year by +21.72%.
Is Willis Towers Watson a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Willis Towers Watson is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 5.25 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WTW as of May 2025 is 316.88. This means that WTW is currently overvalued and has a potential downside of 3.43%.
Is WTW a buy, sell or hold?
Willis Towers Watson has received a consensus analysts rating of 4.11. Therefor, it is recommend to buy WTW.
  • Strong Buy: 8
  • Buy: 5
  • Hold: 4
  • Sell: 1
  • Strong Sell: 0
What are the forecast for WTW stock price target?
According to ValueRays Forecast Model, WTW Willis Towers Watson will be worth about 346 in May 2026. The stock is currently trading at 306.36. This means that the stock has a potential upside of +12.94%.
Issuer Forecast Upside
Wallstreet Target Price 366.3 19.6%
Analysts Target Price 366.2 19.5%
ValueRay Target Price 346 12.9%